Ocular syphilis is re-emerging in Europe and is often first detected by ophthalmologists, with acute placoid chorioretinitis being a common manifestation.

"The world around me collapsed, and I just felt dirty and worthless," Andrew Oakes said, vividly remembering the moment he was diagnosed with HIV at the age of 28. Oakes went to the hospital in 2021 ...

Godfrey Dzhivhuho has dedicated his career to understanding HIV and other infectious diseases, inspired by the epidemic he witnessed growing up. Raised in Warrenton-Kimberly, South Africa, the oldest ...

The plan to target pregnant and breastfeeding mothers will be administered through the President’s Emergency Plan for AIDS Relief. Critics said it appeared to sidestep LGBTQ+ people. The Trump ...

Republicans in the U.S. House of Representatives are aiming to cut $1.7 billion from domestic HIV prevention, treatment, and care programs. On Monday, the Republican-controlled House Appropriations ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

When President Donald Trump began his second term, the world was on the verge of a miracle: ending the global HIV pandemic by 2030. With the first strokes of his pen, Trump set to erase decades of ...

The National Institutes of Health placed a big bet on Oregon scientist Jonah Sacha this week, awarding Sacha and his colleagues an $8.4 million, five-year grant for their work developing a cure for ...

Meeting UNAIDS’ “95/95/95” targets for 2025—95% of people with HIV knowing their status, 95% of those who know their status on treatment, and 95% of people on treatment having a suppressed viral ...

A supercharged vaccine that remains in the lymph nodes for weeks is likelier to generate more antibody variations, strengthening the immune response. A team at MIT and the Scripps Research Institute ...